These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38584926)

  • 1. Corrigendum: Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China.
    Zhu W; Wang X; Lin Y; He L; Zhang R; Wang C; Zhu X; Tang T; Gu L
    Front Public Health; 2024; 12():1397325. PubMed ID: 38584926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China.
    Zhu W; Wang X; Lin Y; He L; Zhang R; Wang C; Zhu X; Tang T; Gu L
    Front Public Health; 2023; 11():1273745. PubMed ID: 38106899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market.
    Luo M; Liu S; Zhu L; Wang F; Wu K; He H; Qi X; Pang Z; Dong X; Gong Z; Yu M
    Front Public Health; 2023; 11():1272251. PubMed ID: 37818299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic surveillance of SARS-CoV-2 in Weihai, China, march 2022 to march 2023.
    Li X; Zhang Y; Zhang J; Sui Z; Qu X; Wang M; Miao T; Li J
    Front Public Health; 2023; 11():1273443. PubMed ID: 38035306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022.
    Novazzi F; Giombini E; Rueca M; Baj A; Fabeni L; Genoni A; Ferrante FD; Gramigna G; Gruber CEM; Boutahar S; Minosse C; Butera O; Pasciuta R; Focosi D; Colombo A; Antinori A; Girardi E; Vaia F; Maggi F
    Euro Surveill; 2023 Jan; 28(2):. PubMed ID: 36695479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis.
    Liu P; Cai J; Tian H; Li J; Lu L; Xu M; Zhu X; Fu X; Wang X; Zhong H; Jia R; Ge Y; Zhu Y; Zeng M; Xu J
    Front Microbiol; 2024; 15():1372078. PubMed ID: 38605705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan.
    Jin B; Oyama R; Tabe Y; Tsuchiya K; Hando T; Wakita M; Yan Y; Saita M; Takei S; Horiuchi Y; Miida T; Naito T; Takahashi K; Ogawa H
    Front Microbiol; 2023; 14():1229234. PubMed ID: 37744926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages.
    Kumar N; Kaushik R; Singh A; Uversky VN; Zhang KYJ; Sahu U; Bhatia S; Sanyal A
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination
    Wang H; Xue Q; Zhang H; Yuan G; Wang X; Sheng K; Li C; Cai J; Sun Y; Zhao J; Lu J; Fang S; Yang Y; Zhang Y; Huang Y; Wang J; Xu JH; Jiang MX; Wang X; Shen L; Liu Y; Liu Q; Zhang Q; Wang S; Wang P; Qiu C; Ai J; Zhang W
    Emerg Microbes Infect; 2023 Dec; 12(2):2249121. PubMed ID: 37668156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.
    Márquez-González H; Méndez-Galván JF; Reyes-López A; Klünder-Klünder M; Jiménez-Juárez R; Garduño-Espinosa J; Solórzano-Santos F
    Front Public Health; 2021; 9():754703. PubMed ID: 34660524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1.
    Liu S; Liang Z; Nie J; Gao WB; Li X; Zhang L; Yu Y; Wang Y; Huang W
    Emerg Microbes Infect; 2023 Dec; 12(2):2225638. PubMed ID: 37313604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regional genomic surveillance program is implemented to monitor the occurrence and emergence of SARS-CoV-2 variants in Yubei District, China.
    Liu F; Deng P; He J; Chen X; Jiang X; Yan Q; Xu J; Hu S; Yan J
    Virol J; 2024 Jan; 21(1):13. PubMed ID: 38191416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study.
    Hu Z; Jin Z; Zhou M; Zhang C; Bao Y; Gao X; Wang G
    J Med Virol; 2023 Oct; 95(10):e29143. PubMed ID: 37814963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China.
    Sun Y; Wang M; Lin W; Dong W; Xu J
    J Biosaf Biosecur; 2023 Mar; 5(1):14-20. PubMed ID: 36718149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: NGS implementation for monitoring SARS-CoV-2 variants in Chicagoland: an institutional perspective, successes and challenges.
    Tartanian AC; Mulroney N; Poselenzny K; Akroush M; Unger T; Helseth DL; Sabatini LM; Bouma M; Larkin PMK
    Front Public Health; 2023; 11():1234900. PubMed ID: 37441637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance.
    Liu D; Wang Z; Mao M; Zhang Z; Ding X; Zheng H; Li S; Zhang Z; Tian Z
    J Med Virol; 2023 Nov; 95(11):e29222. PubMed ID: 37964661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoVe-Tracker: An Interactive SARS-CoV-2 Pan Proteome Evolution Tracker.
    Sathyaseelan C; Magateshvaren Saras MA; Prasad Patro LP; Uttamrao PP; Rathinavelan T
    J Proteome Res; 2023 Jun; 22(6):1984-1996. PubMed ID: 37036263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.